Zepteon
Marc Silver, Strategic Advisor, is a senior executive with broad ranging business management skills gained from over 25 years’ experience in the biopharmaceutical industry. He has developed a range of funded initiatives including new company business plans and new company programs and has a deep track record of transaction negotiation including “out-licensing”, “in-licensing”, partnering and financing. Marc was the VP of business development at BioWa from 2009-2012 and has an MBA from MIT.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Zepteon
Zepteon, Inc. is a privately held corporation founded in 2012 that has developed first in class chromatography resins capable of separating antibodies with specific sugar structures (nonfucosylated) that are more potent against diseases like cancer. This technology enables more effective therapeutics and can reduce cost and dosing requirements.